CompletedNot Applicable

Assessing the Use of Mobile Technology in Adult Asthma Patients

United States104 participantsStarted 2017-04-21

Plain-language summary

This is a prospective, remote observational study of adults with persistent asthma who are managed on inhaled corticosteroids.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Ability to provide written informed consent * Male and female adults (aged ≥ 18 years) * Diagnosis of asthma for at least 6 months * ICS (inhaled corticosteroid) use for at least 3 months * Use of a pressurized metered dose inhaler (pMDI) compatible with the HeroTracker * Possess a compatible smartphone (iOS 8.0 or higher and Android 4.3 or higher) Exclusion Criteria: * Currently pregnant or planning to become pregnant during the study period * Primary language other than English (BreatheSmart mobile app is currently available only in English)

What they're measuring

Change in asthma control

Timeframe: 3 months

Change in rescue medication usage

Timeframe: 3 months

Trial details

NCT IDNCT03103880

SponsorCoheroHealth

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2018-08-29

View on ClinicalTrials.gov More Asthma trials